MedTrace Logo

Expert Statements Concerning the Tapering of Oral Corticosteroids (OCS) for the Treatment of Asthma

NCT03899740 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2019-09-04

No results posted yet for this study

Summary

The objectives of this study are to use the Delphi method to assemble an expert panel representing innovation in asthma treatment, to collect freely suggested recommendation statements concerning OCS tapering (and sub-topics) among severe asthma patients from this panel for peer evaluation, and finally to determine the level of consensus for each statement from the panel as a whole.

Conditions

Interventions

OTHER

Brainstorming 1

Expert recommendation statements will be collected for peer evaluation.

OTHER

Ranking - Round 1

Each participant will rank each statement using a likert scale: strongly disagree -- disagree -- neutral -- agree -- strongly agree.

OTHER

Ranking - Round 2

Each participant will rank each statement using a likert scale: strongly disagree -- disagree -- neutral -- agree -- strongly agree.

OTHER

Ranking - Round 3

Each participant will rank each statement using a likert scale: strongly disagree -- disagree -- neutral -- agree -- strongly agree.

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • University Hospital, Montpellier

    collaborator OTHER

  • Association Jean Baptiste Desbrest

    lead OTHER

Principal Investigators

  • Carey Suehs, PhD · Association Jean Baptiste Desbrest

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2019-09-26
Completion
2019-09-26

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03899740 on ClinicalTrials.gov